109 related articles for article (PubMed ID: 34561331)
1. Nucleolar protein 6 promotes cell proliferation and acts as a potential novel prognostic marker for hepatocellular carcinoma.
Meng L; Xu KX; Zhao MX; Li K; Zhu K; Yuan DW; Wang HN; Dai PG; Yan R
Chin Med J (Engl); 2021 Sep; 134(21):2611-2618. PubMed ID: 34561331
[TBL] [Abstract][Full Text] [Related]
2. NOL6 promotes the proliferation and migration of endometrial cancer cells by regulating
Liang J; Sun W; Song H; Wang C; Li Q; Li C; Wei D; Zhao Y; Li C; Zhang H
Epigenomics; 2021 Oct; 13(19):1571-1585. PubMed ID: 34607487
[TBL] [Abstract][Full Text] [Related]
3. NOL6 Regulates the Proliferation and Apoptosis of Gastric Cancer Cells
He L; Qian X; Ge P; Fan D; Ma X; Wu Q; Sun J; Yang L; Shen J; Xu L
Front Oncol; 2022; 12():708081. PubMed ID: 35494047
[TBL] [Abstract][Full Text] [Related]
4. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
[TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
6. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
7. CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20.
Li F; Liu CS; Wu P; Ling AS; Pan Q; Li XN
Chin Med J (Engl); 2021 Nov; 134(22):2721-2729. PubMed ID: 34732665
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
9. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
10. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
11. NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p.
Dong D; Song M; Wu X; Wang W
Cytotechnology; 2020 Jun; 72(3):469-478. PubMed ID: 32249364
[TBL] [Abstract][Full Text] [Related]
12. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of PPP5C inhibits growth of hepatocellular carcinoma cells in vitro.
Feng L; Sun P; Li Z; Liu M; Sun S
Appl Biochem Biotechnol; 2015 Jan; 175(1):526-34. PubMed ID: 25326185
[TBL] [Abstract][Full Text] [Related]
17. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
18. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.
Wang RP; Jiang J; Jiang T; Wang Y; Chen LX
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082
[TBL] [Abstract][Full Text] [Related]
19. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
[TBL] [Abstract][Full Text] [Related]
20. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.
Zhao Y; Yu Y; Zhao W; You S; Feng M; Xie C; Chi X; Zhang Y; Wang X
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
